Alan Weightman
About Alan Weightman
Alan Weightman is a Technical Business Analyst at HSBC in London, with a strong academic background in Philosophy, Medicine, and Biochemical Engineering. He has extensive experience in software testing, SQL data management, and fostering collaboration across workstreams in the financial sector.
Work at HSBC
Alan Weightman has been employed at HSBC as a Technical Business Analyst since 2017. In this role, he has contributed to various projects, focusing on the development of reporting software. He has led testing and issue resolution efforts during software development and managed releases in testing environments. His responsibilities include fostering collaboration across workstreams through forums such as Requirements Logs and Change Requests. Additionally, he has executed SQL-based data validation routines to support Big Data implementation for financial reporting.
Education and Expertise
Alan Weightman has an extensive educational background, having studied at multiple institutions. He earned a Doctor of Philosophy from Keele University, where he focused on Philosophy and Medicine from 2009 to 2014. Prior to this, he obtained a Master of Science in Biochemical Engineering from the University of Birmingham in 2009. He also holds a Bachelor of Science in Physiology and Pharmacology from The University of Sheffield, completed in 2008. His academic pursuits have equipped him with a strong foundation in both scientific and analytical skills.
Background
Alan Weightman transitioned from a career in science to information technology, specifically in business analysis within the financial sector. His background in science has informed his analytical approach to problem-solving and project management. He has a proven track record of investigating new data attributes to meet evolving reporting requirements for financial data, demonstrating his adaptability and commitment to continuous improvement.
Achievements
During his doctoral studies, Alan Weightman published three research papers focused on the development and optimization of complex biological platforms for treating spinal cord injuries. He also achieved a significant reduction in project expenditure by 20% through the innovation of a reusable consumable item. His contributions to both academic research and practical applications in the financial sector highlight his ability to bridge the gap between theory and practice.